SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950129-05-012222
Filing Date
2005-12-23
Accepted
2005-12-23 13:42:05
Documents
2
Group Members
ESSEX WOODLANDS HEALTH VENTURES FUND VI, L.P.ESSEX WOODLANDS HEALTH VENTURES VI, L.L.C.ESSEX WOODLANDS HEALTH VENTURES VI, L.P.IMMANUEL THANGARAJJAMES L. CURRIEJEFF HIMAWAN, PH.D.MARK PACALAMARTIN P. SUTTERPETRI VAINIO, MD, PH.D.

Document Format Files

Seq Description Document Type Size
1 ESSEX WOODLANDS HEALTH VENTURES FUND VI, L.P. FOR LA JOLLA PHARMACEUTICAL COMPAN h31501sc13d.htm SC 13D 151790
2 JOINT FILING AGREEMENT h31501exv99w1.htm EX-99.1 10403
  Complete submission text file 0000950129-05-012222.txt   164462
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44849 | Film No.: 051284887
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10001 WOODLOCH FOREST DR STE 175 WOODLOCH TX 77380
Business Address 190 S LASALLE ST STE 2800 CHICAGO IL 60603
ESSEX WOODLANDS HEALTH VENTURES FUND IV L P (Filed by) CIK: 0001110080 (see all company filings)

IRS No.: 760573201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D